Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD pl... Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are Product and the Service Segment. The Products segment generates maximum revenue which is engaged in the research and development of aesthetic and therapeutic products. Show more
Crown Laboratories, Inc. (“Crown”), a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc. (“Revance”) (NASDAQ: RVNC), a biotechnology company aimed...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -16.620498615 | 3.61 | 4.17 | 3.01 | 1396712 | 3.94592358 | CS |
4 | -0.765 | -20.2649006623 | 3.775 | 4.365 | 3.01 | 2074630 | 3.88158768 | CS |
12 | -3.535 | -54.0106951872 | 6.545 | 6.55 | 3.01 | 2590662 | 5.02454534 | CS |
26 | 0.35 | 13.1578947368 | 2.66 | 6.65 | 2.3 | 3331906 | 5.36283587 | CS |
52 | -4.34 | -59.0476190476 | 7.35 | 9.745 | 2.3 | 2588855 | 5.27703761 | CS |
156 | -13.14 | -81.3622291022 | 16.15 | 37.98 | 2.3 | 1706458 | 13.16190424 | CS |
260 | -13.33 | -81.5789473684 | 16.34 | 37.98 | 2.3 | 1278805 | 15.09707527 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales